GE Healthcase

Short Name: 
BiaCore
Address: 
GE Healthcare Life Sciences Protein Analysis Rapsgatan 23 SE 751 84 Uppsala, Sweden
Description: 
Biacore is the world leader in the detection and monitoring of protein binding using surface plasmon resonance (SPR) based technology. The Company develops and manufactures advanced bioanalytical systems, which provide real time quantitative data on binding interactions between biomolecules in a label free manner. Since the first commercial product was launched in 1990, Biacore has built an enviable reputation and leadership position in affinitybased biosensors with over 90% market share. Interaction data, as obtained from experiments with Biacore instruments, are reported in more than 6000 peer reviewed publications. Biacore has recently been acquired by GE and is now part of the GE healthcare business.
Principal Investigator: